SLMP53-1 interacts with wild-type and mutant p53 DNA-binding domain and reactivates multiple hotspot mutations

Background Half of human cancers harbour TP53 mutations that render p53 inactive as a tumor suppressor. As such, reactivation of mutant (mut)p53 through restoration of wild-type (wt)-like function represents one of the most promising therapeutic strategies in cancer treatment. Recently, we have repo...

ver descrição completa

Detalhes bibliográficos
Autor principal: Gomes, A. S. (author)
Outros Autores: Ramos, Helena (author), Gomes, S. (author), Loureiro, Joana B. (author), Soares, Joana (author), Barcherini, Valentina (author), Monti, Paola (author), Fronza, Gilberto (author), Oliveira, Carla Cristina Marques de (author), Domingues, Lucília (author), Bastos, Margarida (author), Dourado, Daniel F. A. R. (author), Carvalho, Ana Luísa (author), Romão, Maria João (author), Pinheiro, Benedita (author), Marcelo, Filipa (author), Carvalho, Alexandra (author), Santos, Maria M. M. (author), Saraiva, Lucília (author)
Formato: article
Idioma:eng
Publicado em: 2020
Assuntos:
p53
Mutant
Cancer
Chemotherapy
Reactivator
Ciências Médicas::Biotecnologia Médica
Science & Technology
Texto completo:http://hdl.handle.net/1822/62529
País:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/62529

Texto Completo

http://hdl.handle.net/1822/62529

Registos relacionados